Evidence map›Paper›PMID 28666466›Full record

ArticleArthritis research & therapy2017

Beneficial effect of resveratrol on phenotypic features and activity of osteoarthritic osteoblasts.

Élie Abed, Aline Delalandre, Daniel Lajeunesse

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Identification of ferroptosis-related genes and potential drugs in osteoarthritis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Novel Role of the SIRT1 in Endocrine and Metabolic Diseases.International journal of biological sciences · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Cell Interplay in Osteoarthritis.Frontiers in cell and developmental biology · 2021
    Review
  17. Subchondral Bone Remodeling: A Therapeutic Target for Osteoarthritis.Frontiers in cell and developmental biology · 2020
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Élie AbedUnité de recherche en Arthrose, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900, rue Saint-Denis, Montréal, Québec, H2X 0A9, Canada.
Aline DelalandreUnité de recherche en Arthrose, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900, rue Saint-Denis, Montréal, Québec, H2X 0A9, Canada.
Daniel LajeunesseUnité de recherche en Arthrose, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), 900, rue Saint-Denis, Montréal, Québec, H2X 0A9, Canada. daniel.lajeunesse@umontreal.ca.ORCID 0000-0001-6958-5906
Centre Hospitalier de l’Université de Montréal · CA

Funding

CIHR MOP-49501
6 · The paper itself

Abstract

backgroundOsteoarthritis (OA) is a complex disease, which affects multiple tissues, namely the subchondral bone, articular cartilage and synovial membrane. Alterations of the subchondral bone include an increased, yet under mineralized osteoid matrix, abnormal osteoblast cell phenotype including elevated alkaline phosphatase (ALP) activity, increased release of osteocalcin (OC) and transforming growth factor β-1 (TGF-β1). Previous studies have demonstrated an inhibition of the canonical Wnt signaling (cWnt) pathway in OA osteoblasts (Ob). As resveratrol (RSV) has been shown to upregulate the Wnt signaling pathway in different cell systems, we hypothesized that RSV could be beneficial for OA Ob.

methodWe prepared primary human Ob using the subchondral bone plate of tibial plateaus of OA patients undergoing total knee arthroplasty, or tibial plateaus of normal individuals at autopsy. Sirtuin 1 (Sirt1) expression in normal and OA subchondral bone tissue was evaluated by immunohistochemical analysis. Expression of genes was evaluated by qRT-PCR and protein production by western blot analysis. ALP activity and osteocalcin secretion were evaluated respectively with substrate hydrolysis and enzyme immunoassay. Mineralization levels were evaluated with alizarin red staining. Wnt/β-catenin signaling was evaluated by target gene expression using the TOPflash TCF/lef luciferase reporter assay and intracellular signaling using β-catenin levels in western blot analysis. Extracellular signal-regulated kinase (Erk)1/2 and the Smad1/5/8 pathways were evaluated by western blot analysis.

resultsSirt1 expression and production were reduced in OA subchondral bone tissue compared to normal tissue. RSV upregulated Sirt1 and its activity, and reduced the expression of leptin. RSV increased Erk1/2 phosphorylation in OA Ob; however, it had no effect on Smad 1/5/8 phosphorylation. RSV had little effect on cell proliferation and only slightly affected the Bax/Bcl2 ratio. The expression of Runx2/Cbfa1 and peroxisome proliferator-activated receptor (PPAR)γ were not affected by increasing doses of RSV. The endogenous increased ALP activity and OC release observed in OA Ob compared to normal Ob were partly corrected only for ALP at high RSV levels but not for OC release. In contrast, RSV increased the mineralization of OA Ob. Moreover, whereas Wnt3a stimulates the Wnt/β-catenin pathway in these cells, RSV further increased the response to Wnt3a.

conclusionThese data indicate that RSV promotes Sirt1 levels, inhibits the endogenous expression of leptin by OA osteoblasts and can promote the Wnt/β-catenin and Erk1/2 signaling pathways, which are altered in these cells.

Indexed as

PhenotypeAgedAnimalsAnti-Inflammatory Agents, Non-SteroidalCell LineCells, CulturedDose-Response Relationship, DrugFemaleHumansMaleMiceMiddle AgedOsteoarthritisOsteoblastsResveratrolSirtuin 1Anti-Inflammatory Agents, Non-SteroidalResveratrolSIRT1 protein, humanSirtuin 1StilbenesCanonical Wnt signalingMineralizationOsteoarthritisResveratrolSirtuin 1Subchondral bone

Identifiers

PMID28666466
PMCPMC5493084
OpenAlexW2734148011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.